Corcept Therapeutics | CORT - Interest Income

Stock Price
42.28
Daily Change
-0.21 -0.49%
Monthly
24.39%
Yearly
-43.36%
Q2 Forecast
41.21

Corcept Therapeutics reported $5.02M in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
Acadia Pharmaceuticals USD 8.25M 1M Sep/2025
Aurora Cannabis CAD 1.85M 120K Sep/2025
BioMarin Pharmaceutical USD 17.85M 973K Sep/2025
Corcept Therapeutics USD 5.02M 7K Sep/2025
Eli Lilly USD 65M 25M Sep/2025
Esperion Therapeutics USD -0.15 0.18 Sep/2024
J&J USD 2.12 0.17 Sep/2025
Knight Therapeutics CAD 2.46M 498K Sep/2024
Merck USD 96M 27M Sep/2025
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Pacira USD 8.53M 3.53M Sep/2025
Pfizer USD 0.62 156M Sep/2025
Supernus Pharmaceuticals USD 2.28M 2.25M Sep/2025